Molecular Templates Inc - ESG Rating & Company Profile powered by AI
The webpage of Molecular Templates Inc is assembled by All Street Sevva using proprietary machine learning. Alternative companies in the rating peer group for Molecular Templates Inc are displayed. Check the end of the webpage for potential risks for Molecular Templates Inc based on industry, location and size.
Molecular Templates Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 4.0, social score of 4.8 and governance score of 6.4.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | Molecular Templates Inc | 5.1 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Molecular Templates Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Molecular Templates Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Molecular Templates Inc report the average age of the workforce?
Sign up for free to unlockDoes Molecular Templates Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Molecular Templates Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Molecular Templates Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Molecular Templates Inc offer flexible work?
Sign up for free to unlockDoes Molecular Templates Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Molecular Templates Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Molecular Templates Inc conduct supply chain audits?
Sign up for free to unlockDoes Molecular Templates Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Molecular Templates Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Molecular Templates Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Molecular Templates Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Molecular Templates Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Molecular Templates Inc disclose water use targets?
Sign up for free to unlockDoes Molecular Templates Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Molecular Templates Inc have a product recall in the last two years?
Sign up for free to unlockDoes Molecular Templates Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Molecular Templates Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Molecular Templates Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Molecular Templates Inc disclose parental leave metrics?
Sign up for free to unlockDoes Molecular Templates Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Molecular Templates Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Molecular Templates Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Molecular Templates Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Molecular Templates Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Molecular Templates Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Molecular Templates Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Molecular Templates Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Molecular Templates Inc disclose its waste policy?
Sign up for free to unlockDoes Molecular Templates Inc report according to TCFD requirements?
Sign up for free to unlockDoes Molecular Templates Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Molecular Templates Inc disclose energy use targets?
Sign up for free to unlockDoes Molecular Templates Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Molecular Templates Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Molecular Templates Inc
These potential risks are based on the size, segment and geographies of the company.
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.